ACADIA Pharmaceuticals, Inc. (ACAD)
18.14
-0.23
(-1.25%)
USD |
NASDAQ |
Nov 12, 16:00
18.12
-0.02
(-0.08%)
After-Hours: 20:00
ACADIA Pharmaceuticals Price to Book Value : 2.259 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.259 |
| November 11, 2026 | 2.288 |
| November 10, 2026 | 2.276 |
| November 09, 2026 | 2.055 |
| November 06, 2026 | 2.644 |
| November 05, 2026 | 2.645 |
| November 04, 2026 | 2.674 |
| November 03, 2026 | 2.562 |
| November 02, 2026 | 2.549 |
| October 30, 2026 | 2.564 |
| October 29, 2026 | 2.585 |
| October 28, 2026 | 2.530 |
| October 27, 2026 | 2.512 |
| October 26, 2026 | 2.458 |
| October 23, 2026 | 2.457 |
| October 22, 2026 | 2.529 |
| October 21, 2026 | 2.514 |
| October 20, 2026 | 2.546 |
| October 19, 2026 | 2.466 |
| October 16, 2026 | 2.381 |
| October 15, 2026 | 2.455 |
| October 14, 2026 | 2.397 |
| October 13, 2026 | 2.319 |
| October 12, 2026 | 2.417 |
| October 09, 2026 | 2.463 |
| Date | Value |
|---|---|
| October 08, 2026 | 2.438 |
| October 07, 2026 | 2.447 |
| October 06, 2026 | 2.458 |
| October 05, 2026 | 2.504 |
| October 02, 2026 | 2.484 |
| October 01, 2026 | 2.477 |
| September 30, 2026 | 2.509 |
| September 29, 2026 | 2.664 |
| September 28, 2026 | 2.705 |
| September 25, 2026 | 2.724 |
| September 24, 2026 | 2.922 |
| September 23, 2026 | 3.350 |
| September 22, 2026 | 3.479 |
| September 21, 2026 | 3.477 |
| September 18, 2026 | 3.595 |
| September 17, 2026 | 3.616 |
| September 16, 2026 | 3.628 |
| September 15, 2026 | 3.525 |
| September 14, 2026 | 3.626 |
| September 11, 2026 | 3.666 |
| September 10, 2026 | 3.654 |
| September 09, 2026 | 3.647 |
| September 08, 2026 | 3.633 |
| September 04, 2026 | 3.691 |
| September 03, 2026 | 3.670 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals, Inc. | 11.55 |
| Arcturus Therapeutics Holdings, Inc. | 1.424 |
| ADMA Biologics, Inc. | 6.727 |
| Immunic, Inc. | 0.8331 |
| Viking Therapeutics, Inc. | 5.975 |
Price to Book Value Related Metrics
| PE Ratio | 8.618 |
| PS Ratio | 2.612 |
| PEG Ratio | 0.2433 |
| Price to Free Cash Flow | 38.30 |
| Price | 18.14 |
| Earnings Yield | 11.60% |
| Market Cap | 3.134B |
| PEGY Ratio | 0.2433 |
| Operating PE Ratio | 25.67 |
| Normalized PE Ratio | 8.618 |